Paclitaxel and Tacrolimus Coencapsulated Polymeric Micelles That Enhance the Therapeutic Effect of Drug-Resistant Ovarian Cancer.

PubWeight™: 0.81^‹?›

🔗 View Article (PMID 26809267)

Published in ACS Appl Mater Interfaces on February 09, 2016

Authors

Ning Wang¹, Tao He¹, Yangmei Shen², Linjiang Song¹, Ling Li¹, Xi Yang¹, Xia Li¹, Mengru Pang¹, Weijun Su³, Xinyu Liu¹, Qinjie Wu¹, Changyang Gong¹

Author Affiliations

1: State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy , Chengdu 610041, P. R. China.
2: Department of Gynecology and Obstetrics, Second West China Hospital, Sichuan University , Chengdu 610041, P. R. China.
3: School of Medicine, Nankai University , Tianjin 300071, P. R. China.

Articles citing this ↘

Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo. Int J Nanomedicine (2017) 0.75

Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance. Int J Nanomedicine (2016) 0.75

Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles. Oncotarget (2017) 0.75

Articles by these authors ⇆

Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice. ACS Nano (2016) 0.75

Improving Antiadhesion Effect of Thermosensitive Hydrogel with Sustained Release of Tissue-type Plasminogen Activator in a Rat Repeated-Injury Model. ACS Appl Mater Interfaces (2016) 0.75